The Roadmap should lead to a "commission proposal for a common vaccination card / passport for EU citizens by 2022".
Under the header "Ten Actions Towards Vaccination for All – Everyone should be able to benefit from the power of vaccination", the summit manifesto laments that:
"Despite the availability of safe and effective vaccines, lack of access, vaccine shortages, misinformation, complacency towards disease risks, diminishing public confidence in the value of vaccines and disinvestments are harming vaccination rates worldwide."
And with them, arguably, the pharmaceutical companies' profits.
In July 2017, for example, Italy made 12 vaccinations compulsory for children. In the aftermath, the prices of these very vaccines went up by 62%: from an average price per dose of € 14.02 up to € 22,74.
The global vaccination market is currently worth USD 27 billion a year. According to WHO estimates, it will reach USD 100 billion by 2025.
Since the EC-WHO global vaccination summit also discussed a renewed immunization agenda for 2030, the big pharma's shareholders need not worry for the long-term performance of their stock.
One ought really not to "harm vaccination rates worldwide".